《港股開市》恆指低開53點 科網股及車股偏軟 藥明生物漲近5%
內地官媒文章強調全力維護資本市場穩定運行,切實推動股市健康發展,港股三連升1,250點後,大市今早市低開。恆指低開53點或0.3%,報16,158點;國指低開30點或0.6%,報5,438點;恆生科技指數低開26點或0.8%,報3,284點。
內地本月115款國產網絡遊戲獲批版號,騰訊(00700.HK)低開0.9%報288.2元。其他科網股方面,阿里(09988.HK)、美團(03690.HK)及百度(09888.HK)低開1.3%至1.4%,小米(01810.HK)、京東(09618.HK)及快手(01024.HK)低開不足1%,嗶哩嗶哩(09626.HK)低開3%。網易(09999.HK)高開0.7%報162.6元。
電動車股比亞迪(01211.HK)及理想(02015.HK)低開1.7%,蔚來(09866.HK)及小鵬(09868.HK)低開0.9%及0.8%。汽車代理中升(00881.HK)低開3%。晶片股中芯(00981.HK)高開2.2%,個人電腦生產商聯想集團(00992.HK)低開3%。
其他藍籌方面,匯控(00005.HK)高開0.1%報60.45元,港交所(00388.HK)高開1.6%報249元,友邦(01299.HK)平開報65.05元。藥明生物(02269.HK)高開4.8%,據聯交所資料聯合創辦人董事長李革於本周三(24日)在場內增持523.6萬股,每股作價28.7123元涉1.5億元,里昂指李革自公司2017年上市以來首度增持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.